403 related articles for article (PubMed ID: 19141570)
1. Analysis of chloroethane toxicity and carcinogenicity including a comparison with bromoethane.
Holder JW
Toxicol Ind Health; 2008 Nov; 24(10):655-75. PubMed ID: 19141570
[TBL] [Abstract][Full Text] [Related]
2. Bromoethane, chloroethane and ethylene oxide induced uterine neoplasms in B6C3F1 mice from 2-year NTP inhalation bioassays: pathology and incidence data revisited.
Picut CA; Aoyama H; Holder JW; Gold LS; Maronpot RR; Dixon D
Exp Toxicol Pathol; 2003 Jul; 55(1):1-9. PubMed ID: 12940622
[TBL] [Abstract][Full Text] [Related]
3. Early changes in sex hormones are not evident in mice exposed to the uterine carcinogens chloroethane or bromoethane.
Bucher JR; Morgan DL; Adkins B; Travlos GS; Davis BJ; Morris R; Elwell MR
Toxicol Appl Pharmacol; 1995 Jan; 130(1):169-73. PubMed ID: 7839365
[TBL] [Abstract][Full Text] [Related]
4. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
5. NTP technical report on the toxicity studies of malachite green chloride and leucomalachite green (CAS Nos. 569-64-2 and 129-73-7) administered in feed to F344/N rats and B6C3F1 mice.
Culp SJ
Toxic Rep Ser; 2004 Jun; (71):1-F10. PubMed ID: 15213768
[TBL] [Abstract][Full Text] [Related]
6. Examination of low-incidence brain tumor responses in F344 rats following chemical exposures in National Toxicology Program carcinogenicity studies.
Sills RC; Hailey JR; Neal J; Boorman GA; Haseman JK; Melnick RL
Toxicol Pathol; 1999; 27(5):589-99. PubMed ID: 10528639
[TBL] [Abstract][Full Text] [Related]
7. Physiologically based pharmacokinetic modeling of chloroethane disposition in mice, rats, and women.
Gargas ML; Sweeney LM; Himmelstein MW; Pottenger LH; Bus JS; Holder JW
Toxicol Sci; 2008 Jul; 104(1):54-66. PubMed ID: 18385209
[TBL] [Abstract][Full Text] [Related]
8. Review of the carcinogenic activity of diethanolamine and evidence of choline deficiency as a plausible mode of action.
Leung HW; Kamendulis LM; Stott WT
Regul Toxicol Pharmacol; 2005 Dec; 43(3):260-71. PubMed ID: 16188361
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of potential human carcinogenicity of the synthetic monomer ethyl acrylate.
Williams GM; Iatropoulos MJ
Regul Toxicol Pharmacol; 2009 Feb; 53(1):6-15. PubMed ID: 18930102
[TBL] [Abstract][Full Text] [Related]
10. The rodent carcinogenicity bioassay produces a similar frequency of tumor increases and decreases: implications for risk assessment.
Davies TS; Monro A
Regul Toxicol Pharmacol; 1994 Dec; 20(3 Pt 1):281-301. PubMed ID: 7724835
[TBL] [Abstract][Full Text] [Related]
11. Toxicology and carcinogenesis studies of malachite green chloride and leucomalachite green. (CAS NOS. 569-64-2 and 129-73-7) in F344/N rats and B6C3F1 mice (feed studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2005 Feb; (527):1-312. PubMed ID: 15891780
[TBL] [Abstract][Full Text] [Related]
12. Toxicity and carcinogenicity of Elmiron in F344/N rats and B6C3F1 mice following 2 years of gavage administration.
Abdo KM; Johnson JD; Nyska A
Arch Toxicol; 2003 Dec; 77(12):702-11. PubMed ID: 14508637
[TBL] [Abstract][Full Text] [Related]
13. NTP technical report on the toxicology and carcinogenesis studies of anthraquinone (CAS No. 84-65-1) in F344/N rats and B6C3F1 mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2005 Sep; (494):1-358. PubMed ID: 16362060
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of estrogen receptor expression in the uterus of ovariectomized B6C3F1 mice and Ishikawa cells treated with bromoethane.
Aoyama H; Couse JF; Hewitt SC; Haseman JK; He H; Zheng X; Majstoravich S; Korach KS; Dixon D
Toxicol Appl Pharmacol; 2005 Dec; 209(3):226-35. PubMed ID: 15922381
[TBL] [Abstract][Full Text] [Related]
15. Toxicology and carcinogenesis studies of sodium chlorate (Cas No. 7775-09-9) in F344/N rats and B6C3F1 mice (drinking water studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2005 Dec; (517):1-255. PubMed ID: 16362061
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the cancer potential of methanol.
Cruzan G
Crit Rev Toxicol; 2009; 39(4):347-63. PubMed ID: 19514918
[TBL] [Abstract][Full Text] [Related]
17. Nitrobenzene carcinogenicity in animals and human hazard evaluation.
Holder JW
Toxicol Ind Health; 1999 Aug; 15(5):445-57. PubMed ID: 10487355
[TBL] [Abstract][Full Text] [Related]
18. NTP technical report on the toxicology and carcinogenesis studies of propylene glycol mono-t-butyl ether (CAS No. 57018-52-7) in F344/N rats and B6C3F1 mice and a toxicology study of propylene glycol mono-t-butyl ether in male NBR rats (inhalation studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2004 Mar; (515):1-306. PubMed ID: 15146215
[TBL] [Abstract][Full Text] [Related]
19. Dimethylarsinic acid: results of chronic toxicity/oncogenicity studies in F344 rats and in B6C3F1 mice.
Arnold LL; Eldan M; Nyska A; van Gemert M; Cohen SM
Toxicology; 2006 Jun; 223(1-2):82-100. PubMed ID: 16677751
[TBL] [Abstract][Full Text] [Related]
20. Ethyl tertiary-butyl ether: a toxicological review.
McGregor D
Crit Rev Toxicol; 2007 May; 37(4):287-312. PubMed ID: 17453936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
